The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: A meta-analysis

Histopathology

Volumn 64, Issue 5, 2014, Pages 701-712

  Lv, Shunzeng ^a   Yang, Yakun ^a   Kwon, Sera ^b   Han, Mingzhi ^c   Zhao, Fangfang ^d   Kang, Huihui ^d   Dai, Congxin ^a   Wang, Renzhi ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b UNIVERSITY OF TORONTO   (Canada)

^c SHANDONG UNIVERSITY   (China)

^d THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Clinicopathological features; Colorectal carcinoma; CXCR4; Meta analysis; Prognosis

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CXCR4 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; CANCER GRADING; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER STAGING; CLINICAL FEATURE; COLORECTAL CARCINOMA; DISTANT METASTASIS; GENETIC HETEROGENEITY; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; TUMOR INVASION; COLORECTAL TUMOR; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; GENETICS; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; META ANALYSIS; METABOLISM; PATHOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; PROGNOSIS; RECEPTORS, CXCR4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84896135102     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12321     Document Type: Article

References (38)

1. Potter JD. Colorectal cancer: molecules and populations. J. Natl Cancer Inst. 1999; 91; 916-932.
2. Narayan S, Roy D. Role of APC and DNA mismatch repair genes in the development of colorectal cancers. Mol. Cancer 2003; 2; 41.
3. Boo YJ, Park JM, Kim J et al. L1 expression as a marker for poor prognosis, tumour progression, and short survival in patients with colorectal cancer. Ann. Surg. Oncol. 2007; 14; 1703-1711.
4. Feezor RJ, Copeland EM, Hochwald SN. Significance of micrometastases in colorectal cancer. Ann. Surg. Oncol. 2002; 9; 944-953.
5. Burger M, Glodek A, Hartmann T et al. Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells. Oncogene 2003; 22; 8093.
6. Staller P, Sulitkova J, Lisztwan J et al. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 2003; 425; 307.
7. Margolin DA, Silinsky J, Grimes C et al. Lymph node stromal cells enhance drug-resistant colon cancer cell tumour formation through SDF-1alpha/CXCR4 paracrine signaling. Neoplasia 2011; 13; 874.
8. Schimanski CC, Schwald S, Simiantonaki N et al. Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. Clin. Cancer Res. 2005; 11; 1743-1750.
9. Schimanski CC, Bahre R, Gockel I et al. Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4. Br. J. Cancer 2006; 95; 210-217.
10. Wang L, Yang B, Yang Q et al. Strong expression of chemokine receptor CXCR4 by renal cell carcinoma cells correlates with metastasis. Clin. Exp. Metastasis 2009; 26; 1049-1054.
11. Jiang YP, Wu XH, Shi B et al. Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumour progression. Gynecol. Oncol. 2006; 103; 226-233.
12. Kang H, Watkins G, Douglas-Jones A et al. The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer. Breast 2005; 14; 360-367.
13. Yopp AC, Shia J, Butte JM et al. CXCR4 expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases. Ann. Surg. Oncol. 2012; 19(Suppl. 3); S339-S346.
14. Ottaiano A, Franco R, Aiello Talamanca A et al. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients. Clin. Cancer Res. 2006; 12; 2795-2803.
15. Hu D, Du C, Xue W, Dou F, Yao Y, Gu J. The expression of chemokine receptors CCR6, CXCR2 and CXCR4 is not organ-specific for distant metastasis in colorectal cancer: a comparative study. Histopathology 2013; 63; 167-173.
16. Kim J, Takeuchi H, Lam ST et al. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J. Clin. Oncol. 2005; 23; 2744-2753.
17. Kim J, Mori T, Chen SL et al. Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome. Ann. Surg. 2006; 244; 113-120.
18. Yoshitake N, Fukui H, Yamagishi H et al. Expression of SDF-1 alpha and nuclear CXCR4 predicts lymph node metastasis in colorectal cancer. Br. J. Cancer 2008; 98; 1682-1689.
19. Zhang NH, Li J, Li Y et al. Co-expression of CXCR4 and CD133 proteins is associated with poor prognosis in stage II-III colon cancer patients. Exp. Ther. Med. 2012; 3; 973-982.
20. Sakai N, Yoshidome H, Shida T et al. CXCR4/CXCL12 expression profile is associated with tumour microenvironment and clinical outcome of liver metastases of colorectal cancer. Clin. Exp. Metastasis 2012; 29; 101-110.
21. Zhang SS, Han ZP, Jing YY et al. CD133(+) CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients. BMC Med. 2012; 10; 85.
22. Wang SC, Lin JK, Wang HS et al. Nuclear expression of CXCR4 is associated with advanced colorectal cancer. Int. J. Colorectal. Dis. 2010; 25; 1185-1191.
23. Saigusa S, Toiyama Y, Tanaka K et al. Stromal CXCR4 and CXCL12 expression is associated with distant recurrence and poor prognosis in rectal cancer after chemoradiotherapy. Ann. Surg. Oncol. 2010; 17; 2051-2058.
24. Wu Y, Jin M, Xu H et al. Clinicopathologic significance of HIF-1α, CXCR4, and VEGF expression in colon cancer. Clin. Dev. Immunol. 2010; 2010; 537531.
25. Ingold B, Schulz S, Budczies J et al. The role of vascular CXCR4 expression in colorectal carcinoma. Histopathology 2009; 55; 576-586.
26. Hu T, Yao Y, Yu S et al. Clinicopathologic significance of CXCR4 and Nrf2 in colorectal cancer. J. Biomed. Res. 2013; 27; 283-290.
27. Speetjens FM, Liefers GJ, Korbee CJ et al. Nuclear localization of CXCR4 determines prognosis for colorectal cancer patients. Cancer Microenviron. 2009; 2; 1-7.
28. Steels E, Paesmans M, Berghmans T et al. Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis. Eur. Respir. J. 2001; 8; 705-719.
29. Tierney JF, Stewart LA, Ghersi D et al. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007; 7; 8-16.
30. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat. Med. 1998; 17; 2815-2834.
31. Egger M, Davey Smith G, Schneider M et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315; 629-634.
32. Fulton AM. The chemokine receptors CXCR4 and CXCR3 in cancer. Curr. Oncol. Rep. 2009; 11; 125-131.
33. Begg CB, Berlin JA. Publication bias: a problem in interpreting medical data. J. R. Stat. Soc. Ser. A Stat. Soc. 1988; 151; 419-463.
34. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50; 1088-1101.
35. Cao NY, Zuo FR. Expression and relationship of CXCR4 in colorectal carcinoma with clinicopathological parameters. Chin. J. Gen. Surg. 2011; 1; 482-486.
36. Pang QH, Zhang XH, Zhang JY et al. Correlative studies on expression of CXCR4, CXCR12, Fascin and E-cadherin in colorectal carcinoma with lymphatic metastasis. Chin. J. Clin. Oncol. 2009; 36; 151-156.
37. Wang L, Li JW, Feng B et al. The expression of chemokine receptor CXCR4 in colorectal cancer and its clinical significance. J. Surg. Concepts Pract. 2009; 14; 189-192.
38. Xu FY, Zhong BT, Wang FJ. The correlation between NF-κB, CXCR4 expressions and their prognostic significance in colorectal carcinoma. J. Hangzhou Normal Univ. 2007; 27; 5-9.